LAVA Therapeutics N.V. (LVTX)

NASDAQ: LVTX · IEX Real-Time Price · USD

3.030

-0.070 (-2.26%)

At close: May 3, 2024, 4:00 PM

2.950

-0.080 (-2.64%)

After-hours: May 3, 2024, 5:55 PM EDT

LAVA Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-41.97	-31.91	-42.36	-15.93	-9.69
Depreciation & Amortization	1.28	0.78	0.56	0.46	0.26
Share-Based Compensation	5.04	4.11	3.91	0.56	0.19
Other Operating Activities	-3.32	31.06	9.24	5.6	0.62
Operating Cash Flow	-38.97	4.04	-28.65	-9.31	-8.62
Capital Expenditures	-0.73	-0.59	-0.76	-0.5	-0.76
Change in Investments	-16.91	9.93	-42.78	0	-0.03
Investing Cash Flow	-17.64	9.35	-43.55	-0.5	-0.79
Share Issuance / Repurchase	0	0.02	89.02	-4.85	0
Debt Issued / Paid	-0.57	0.27	0.34	1.79	1.18
Other Financing Activities	-	-	61.8	22.03	-
Financing Cash Flow	-0.57	0.28	151.16	18.97	1.18
Exchange Rate Effect	1.08	-4.21	-3.92	-0.68	-0.43
Net Cash Flow	-57.18	13.67	78.97	9.16	-8.23
Free Cash Flow	-39.7	3.46	-29.41	-9.81	-9.38
Free Cash Flow Margin	-586.53%	17.82%	-549.74%	-261.78%	-
Free Cash Flow Per Share	-1.49	0.13	-1.49	-24.58	-20.95

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).